FDA Pushes Final Generic Labeling Rule To July

By Dani Kass (December 3, 2015, 6:48 PM EST) -- The U.S. Food and Drug Administration has pushed back to July the release of a final rule allowing generic-drug makers to update safety labels detailing new risks without agency approval. 

In December 2014, the agency had said the rule would be finalized by September 2015, according to the nonprofit Public Citizen, who said their 2011 petition led to the proposed rule. The Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, introduced in 2013, would make it easier for generic-drug makers to update labels with new safety information, according to the FDA's website.

Brand-name drugmakers can change their labels...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!